# Immunomodulatory microneedles restore mitochondrial homeostasis and balance TGF-β/TNF-α signaling to accelerate diabetic wound repair

**Authors:** Minjian Liao, Xinmin Guo, Longbao Feng, Qing Peng, Jianhao Liang, Aleh Kuzniatsou, Rui Guo, Pan Yu, Shuqin Zhou

PMC · DOI: 10.1016/j.mtbio.2025.102687 · Materials Today Bio · 2025-12-14

## TL;DR

This paper introduces microneedles that help heal diabetic wounds by fighting bacteria, reducing inflammation, and restoring mitochondrial function.

## Contribution

A novel microneedle design combining materials and a composite to regulate immune signaling and accelerate diabetic wound repair.

## Key findings

- The MXZ composite achieved over 99% bacterial inhibition against E. coli and S. aureus.
- SHC + MXZ microneedles promoted angiogenesis and reduced inflammation by modulating TGF-β and TNF-α pathways.
- The microneedles restored mitochondrial membrane potential and function impaired by ROS.

## Abstract

Diabetic infected wounds bring great physical and psychological burden to patients. To solve this problem, removing bacteria and regulating the local immune microenvironment have become effective measures. However, traditional wound repair materials are difficult to break through the bacterial biofilm covering the wound site and thus cannot effectively regulate the internal immune environment of the wound. A bilayer multifunctional sulfonated chitosan (SCS)/methacrylated hyaluronic acid (HAMA)/methacrylated collagen III (ColIIIMA) (SCS/HAMA/ColIIIMA, SHC) microneedle loaded with MXene@Zn-MOF (MXZ) composite was designed for diabetic infected wound repair. The MXZ composite achieved more than 99 % bacterial inhibition against both E. coli and S. aureus, and was able to effectively remove the bacterial biofilm. In addition, SHC + MXZ microneedles were able to promote angiogenesis by activating the Transforming Growth Factor-β (TGF-β) signaling pathway. It also regulated macrophage polarization towards the M2 phenotype and inhibited the Tumor Necrosis Factor-α (TNF-α) signaling pathway to reduce the level of inflammation. Further studies on mitochondrial membrane potential showed that SHC + MXZ microneedles were able to restore the decrease in mitochondrial membrane potential caused by ROS and then restore mitochondrial function. In diabetic infected wound repair results showed that SHC + MXZ microneedles effectively promoted diabetic infected wound repair by promoting angiogenesis and reducing the inflammation level of the wound tissue. Finally, the regulation of related gene expression was explored by transcriptome sequencing, and the intrinsic mechanism of SHC MXZ microneedles in promoting the repair of diabetic infected wounds by regulating the TGF-β and TNF-α signaling pathways was elucidated.

Image 1

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** Diabetic infected wounds (MESH:D014946), inflammation (MESH:D007249), diabetic (MESH:D003920)
- **Chemicals:** ColIIIMA (-)
- **Species:** Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12774784/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12774784/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12774784/full.md

---
Source: https://tomesphere.com/paper/PMC12774784